PARKER HANNIFIN CORP

Discover how Parker Hannifin’s precision‑fluidics partnership is reshaping office‑based gynecology, boosting productivity, and driving a 9% CAGR in medical sales.

Parker‑Hannifin’s dual senior note issuances strengthen its long‑term financing, refinance a Filtration Group loan, and boost flexibility to invest in R&D and sustainable consumer products.

Inside Parker‑Hannifin’s latest Form 4: a senior exec’s modest stock buy signals confidence in $1.2 B of 2027 CapEx, laser‑CNC, digital twins, and supply‑chain resilience—boosting productivity in a shifting heavy‑industry landscape.

Explore how Parker Hannifin’s dividend strategy and e‑voting shift, coupled with a former PRH exec’s move to Robertshaw, reshape growth, governance, and competition in industrial equipment.

Executive Bracht Berend boosts Parker‑Hannifin shares in August 2026 Form 4 filing, showing increased ownership and alignment with company performance.

Explore how Parker‑Hannifin’s modest share sale highlights its $1.8 B CapEx strategy, digital twin tech, and supply‑chain resilience driving future growth.

Discover how Parker‑Hannifin’s new S‑3 shelf registration can fuel strategic growth—acquisitions, debt refinancing, and global projects—while navigating industry risks.

How Parker Hannifin’s acquisition of Filtration Group boosts filtration tech, cross‑sell power, and aftermarket cash flow for steady EPS growth.

Explore Parker Hannifin’s undervaluation, cash‑flow strength, and growth levers in motion & fluid control, while weighing macro‑risk and regulatory impact.

Explore how Parker Hannifin’s motion‑control tech, ESG compliance, and AI‑powered digital twins position it to grow in data‑centre and green‑infrastructure markets.